View Article

Abstract

In order to guarantee medicine safety, effectiveness, and patient compliance, pharmaceutical packaging is essential. This comprehensive review examines the critical aspects of pharmaceutical packaging, encompassing its functions, regulatory compliance, and innovative advancements. Packaging serves as the first defense against contamination, degradation, and tampering, maintaining drug stability through specialized materials like inert glass and high-quality plastics. Moreover, it enhances patient compliance with user-friendly designs such as blister and calendar packs. The pharmaceutical packaging market is expected to increase at a compound annual growth rate (CAGR) of 9.7?tween 2024 and 2030 due to changing regulatory requirements and technological advancements. Innovations such as smart packaging, sustainable materials, and patient-centric designs are reshaping the industry. Smart packaging incorporates sensors and digital tools to improve traceability and patient adherence, while eco-friendly solutions address environmental concerns. Regulatory bodies like the FDA and EMA ensure packaging meets safety and efficacy standards. Future trends emphasize personalized solutions, integrating AI and IoT for enhanced medication management and operational efficiency. This review highlights the need for continued research and development to address emerging challenges, ensuring that pharmaceutical packaging remains a cornerstone of healthcare innovation.

Keywords

Pharmaceutical Packaging, Smart Packaging, Sustainability, Patient Compliance.

Introduction

In order to guarantee medicine safety, effectiveness, and patient compliance, pharmaceutical packaging is essential. It serves as the first line of defense against various environmental factors that could compromise the integrity of pharmaceutical products. This review will explore the multifaceted importance of pharmaceutical packaging, focusing on its functions, regulatory compliance, and innovative advancements that enhance patient outcomes. Ensuring Medication Safety-The primary function of pharmaceutical packaging is to protect medications from contamination, degradation, and tampering. Packaging materials must be designed to create a barrier against external elements such as moisture, light, and oxygen, which can adversely affect drug stability and efficacy. Moreover, sterile packaging techniques, such as aseptic filling for injectable medications, are crucial in preventing microbial contamination during storage and transport. Tamper-evident features are also essential in pharmaceutical packaging  assuring consumers that the product is safe for use [1]. Maintaining Efficacy- Packaging for pharmaceuticals is important in maintaining medication efficacy by protecting drugs from environmental factors and preventing interactions with packaging materials. For instance, inert glass containers are often used for sensitive medications to ensure stability. Proper labeling is equally important, providing essential information like dosage, storage conditions, and expiration dates, which helps prevent errors and ensures safe use by patients and healthcare providers [2]. Promoting Patient Compliance-Effective pharmaceutical packaging also plays a vital role in enhancing patient compliance with prescribed regimens. Packaging solutions that facilitate easy access to medications—such as blister packs or calendar packs—are designed to help patients manage their doses effectively. These user-friendly designs make it easier for patients to adhere to their treatment plans by organizing doses clearly and reducing the likelihood of missed or incorrect dosages. Regulatory Compliance - The packaging of pharmaceuticals must adhere to strict regulations established by different health authorities around the globe. These regulations ensure that packaging meets safety standards while safeguarding public health. For instance, child-resistant packaging is mandated for certain medications to prevent accidental ingestion by children. Serialization practices have also become increasingly important for tracking pharmaceutical products throughout the supply chain, thereby enhancing transparency and reducing the risk of counterfeit drugs entering the market.Regulatory bodies such as the FDA (United States), EMA (European Union), and WHO (World Health Organization) provide guidelines that govern the design and manufacturing processes of pharmaceutical packaging [3].

Market Overview

The pharmaceutical packaging market is experiencing significant growth, driven by advancements in technology, increasing regulatory demands, and evolving consumer preferences. This overview will present key statistics on the market's expansion and highlight emerging trends shaping its future. Statistics on Market Growth The pharmaceutical packaging market was estimated to be worth $139.37 billion globally as of 2023. From 2024 to 2030, it is anticipated to expand at a compound annual growth rate (CAGR) of 9.7%, demonstrating the pharmaceutical industry's strong need for creative packaging solutions. The United States remains the largest pharmaceutical market globally, supported by extensive healthcare systems, high per capita income, and substantial investments in drug development. The rising importance of generic drugs and improved access to healthcare services are anticipated to further enhance opportunities within the pharmaceutical packaging landscape . Emerging trends in pharmaceutical packaging highlight a focus on sustainability, smart technology, patient-centric designs, regulatory compliance, and digital integration. Sustainability drives the adoption of eco-friendly materials like recyclables and plant-based plastics, with the market expected to grow significantly. Smart packaging, featuring sensors and RFID tags, enhances traceability, prevents counterfeiting, and improves adherence through tools like reminder-enabled blister packs. Patient-centric designs prioritize accessibility with easy-open and senior-friendly features, while personalized medicine demands customized solutions. Regulatory compliance ensures product authenticity with tamper-evident seals and unique identifiers. Additionally, digital integration, such as AR and interactive QR codes, educates patients and enhances healthcare experiences [4] .

Types Of Packaging

Primary Packaging:

Primary packaging is a crucial aspect of the pharmaceutical industry, as it encompasses the materials that come into direct contact with the drug. This type of packaging is designed to protect the medication from environmental factors, ensure its stability, and maintain its efficacy until it reaches the patient. Glass and plastic are key materials in pharmaceutical packaging, each with distinct advantages. Glass, commonly used in vials and ampoules, is chemically inert, protecting drugs from reactions, moisture, and light while allowing easy inspection of contents. However, its fragility requires careful handling. Plastic, used in bottles and blister packs, is lightweight, flexible, and cost-effective but less inert than glass, with potential for drug interaction or leaching. High-quality plastic formulations are essential to ensure safety and drug stability.

  1. Blister packaging is particularly common for solid dosage forms like tablets and capsules. It consists of a pre-formed plastic cavity (blister) that holds individual doses securely, typically covered by a peelable foil layer. This type of packaging not only protects the medication from moisture and light but also allows for easy access for patients. Blister packs can be designed with child-resistant features to enhance safety. The use of aluminum foil in blister packs provides an excellent barrier against external elements while maintaining product integrity.

       
            Figure 1.png
       

(Figure 1)

  1. Ampoules and vials are airtight glass containers primarily used for storing liquid medications and injectables. Ampoules are sealed by melting the neck after filling, ensuring sterility and preventing contamination. Vials often come with rubber stoppers and aluminium seals to maintain sterility while allowing access via syringes. Both ampoules and vials are essential for parenteral drug delivery systems, where maintaining sterility is paramount. Ampoules and vials are airtight glass containers primarily used for storing liquid medications and injectables. Ampoules are sealed by melting the neck after filling, ensuring sterility and preventing contamination. Vials often come with rubber stoppers and aluminium seals to maintain sterility while allowing access via syringes. Both ampoules and vials are essential for parenteral drug delivery systems, where maintaining sterility is paramount.

       
            Figure 2.png
       

(Figure 2)

  1. Syringes serve as both primary packaging and a delivery device for injectable medications. They are typically made from plastics or glass and can be pre-filled or used as disposable devices. Pre-filled syringes offer convenience for patients by eliminating the need for manual filling, reducing the risk of dosing errors. The design of syringes must ensure compatibility with various medications while maintaining sterility throughout their shelf life [5].

       
            Figure 3.png
       

(Figure 3)

Secondary Packaging

Secondary packaging serves as the outer layer of packaging that groups and protects primary packages, which contain the pharmaceutical products themselves. This layer is essential for ensuring the safe transport and storage of medications while also providing important information to consumers and healthcare professionals.  The primary function of secondary packaging is to provide an additional layer of protection for the primary packagingThis entails protecting the contents from environmental elements like light, moisture, and temperature changes as well as from physical harm during storage and transit. Secondary packaging contributes to the stability and effectiveness of pharmaceutical items over the course of their shelf life by strengthening the primary packaging's durability. Furthermore, because it acts as a canvas for product information, logos, and design aspects that aid in product differentiation in a competitive market, secondary packaging frequently plays a critical part in branding and marketing.

Cartons

  1. Paperboard Boxes
  2. Shrink Wraps
  3. Trays

 

 


       
            Figure 4.png
       

    

 


       
            Figure 5.jpg
       

    

(Figure 4)                      (Figure 5)

 

The choice of materials for secondary packaging is influenced by factors such as product type, regulatory requirements, cost considerations, and environmental sustainability. Common materials include. Convenience and Handling Secondary packaging is designed not only for protection but also for convenience in handling and distribution. Features such as easy-open seals, ergonomic designs, and unit-dose packaging enhance user experience by simplifying access to medications. Additionally, well-designed secondary packages can facilitate efficient stacking and storage during transportation, optimizing space utilization within warehouses and pharmacies [6 ,7].

Tertiary packaging

Tertiary packaging is an essential component of the pharmaceutical supply chain, primarily focused on bulk handling and shipping. This layer of packaging encompasses containers such as pallets, crates, and bulk containers that facilitate the transportation of multiple primary and secondary packages. The primary function of tertiary packaging is to provide efficient bulk handling and transportation of pharmaceutical products. By grouping multiple secondary packages together, tertiary packaging ensures that medications are protected during transit and storage. This layer of packaging plays a vital role in maintaining the integrity of the products by preventing damage from external forces and environmental conditions. Additionally, tertiary packaging enhances logistical efficiency by enabling easier loading and unloading processes, optimizing space utilization during transportation, and facilitating inventory management.

  1. Pallets
  2. Crates
  3. Bulk Containers
  4. Shrink Wraps.

 

 


       
            Figure 6.png
       

    

 


       
            Figure 7.jpg
       

    

(Figure 6)                                          (Figure 7)

 

Often used for pallets and crates due to its strength and availability. Wooden pallets are widely utilized in the pharmaceutical industry but may require treatment to prevent contamination. Plastic pallets and containers are increasingly popular due to their lightweight properties, durability, and resistance to moisture. They are also easier to clean and sanitize compared to wooden alternatives. Metal containers provide superior strength and durability for heavy or sensitive pharmaceutical products. They are often used when maximum protection is required during transport.

Advantages

  1. By grouping multiple packages together, tertiary packaging simplifies handling processes at warehouses and distribution centers. This leads to faster loading times and reduced labor costs.
  2. Tertiary packaging provides an additional layer of protection against physical damage during transit. This is particularly important for fragile or sensitive pharmaceutical products that require careful handling.
  3. Standardized tertiary packaging allows for better organization within warehouses and facilitates easier tracking of inventory throughout the supply chain.
  4. By optimizing space utilization during transport and reducing handling time, tertiary packaging can lead to significant cost savings in logistics operations.

Key Functions

Containment is one of the fundamental functions of pharmaceutical packaging, serving as the first line of defense in ensuring that medications remain stable, effective, and safe for use. This aspect of packaging encompasses various design considerations and material choices that collectively work to prevent leakage, diffusion, and permeation of the product. [4,8,9] .

Protection is a fundamental function of pharmaceutical packaging, crucial for safeguarding medications against various environmental factors such as light, moisture, and oxygen. These external elements can significantly impact the stability, efficacy, and safety of pharmaceutical products. [10,11].

Information Delivery is a critical function of pharmaceutical packaging, as it ensures that essential information about the medication is effectively communicated to healthcare professionals and patients. This function encompasses the use of labels, package inserts, and other informational materials that provide vital details regarding the drug's usage, safety, and storage.

Tamper Evidence is a crucial function of pharmaceutical packaging that ensures the integrity and safety of medications by providing visible indications of any unauthorized access or tampering. This function has gained significant importance in the wake of various incidents involving product tampering, most notably the Tylenol poisoning case in the 1980s, which led to increased regulatory scrutiny and the establishment of tamper-evident packaging requirements.

  1. Tamper-Evident Seals
  2. Breakable Caps
  3. Shrink Bands
  4. Tear Strips
  5. Color-Changing Inks
  6. Intelligent Packaging Solutions [10].

Innovative Packaging Technologies

Smart packaging is an innovative approach that incorporates advanced technologies, such as sensors, to monitor and enhance the safety, quality, and efficiency of pharmaceutical products. This technology is particularly crucial in the pharmaceutical sector, where maintaining the integrity of medications is paramount.

  1. Real-Time Monitoring
  2. Active Interaction
  3. Enhanced Traceability

Benefits of Smart Packaging

  1. Improved Product Safety
  2. Increased Efficiency
  3. Sustainability [11-13]

Child-resistant packaging (CRP) is a crucial innovation in the pharmaceutical industry aimed at preventing accidental ingestion of medications and hazardous substances by children. With the rising awareness of child safety, manufacturers are increasingly focused on developing packaging solutions that are both effective in safeguarding children and accessible for adults, particularly seniors. Accidental poisoning remains a significant public health concern, particularly among young children aged 1 to 5 years. According to the World Health Organization, medicines are a leading cause of non-fatal poisoning incidents globally. Child-resistant packaging is designed to mitigate this risk by making it difficult for children to open containers that hold potentially harmful substances. The implementation of CRP is not just a regulatory requirement; it reflects a commitment to consumer safety and responsible manufacturing practices.

  1. Multi-Step Opening Mechanisms
  2. Locked4Kids Packaging
  3. Smart Packaging Techologies
  4. Visual Distraction Technologies [8,14-16]

Anti-counterfeit measures in pharmaceutical packaging are essential for safeguarding consumer health and maintaining the integrity of medications. With the increasing prevalence of counterfeit drugs, which pose significant risks to public safety, innovative technologies such as holograms, QR codes, and RFID (Radio Frequency Identification) are being adopted to combat this growing threat.

  1. Holograms
  2. QR Codes
  3. RFID Technology

       
            fig-8.png
       

    Biodegradable Materials are becoming increasingly important in the quest for sustainable packaging solutions within the pharmaceutical industry. As concerns about plastic waste and environmental impact grow, innovative biodegradable packaging options are emerging to reduce the ecological footprint of packaging materials. Biodegradable packaging refers to materials that can decompose naturally through the action of microorganisms such as bacteria, fungi, and algae. This ability to break down and return to their natural state contributes significantly to reducing waste accumulation in landfills and minimizing environmental pollution. Unlike traditional plastics, which can take hundreds of years to decompose, biodegradable materials are designed to degrade within a much shorter timeframe—typically within a year or less—depending on environmental conditions.

  1. Cornstarch-Based Materials
  2. Mushroom Packaging
  3. Seaweed Packaging
  4. Paper and Cardboard
  5. Bio-Plastics
  6. Bamboo [8,20-24]

Patient-Centric Designs

Accessibility Features in pharmaceutical packaging are essential for ensuring that visually impaired patients can safely and effectively use their medications. One of the most significant innovations in this area is the incorporation of Braille labels, which provide critical information in a tactile format. Accessibility features in pharmaceutical packaging are vital for empowering visually impaired individuals to independently manage their medications. The ability to read labels and understand dosage instructions is crucial for ensuring that patients take their medications correctly and safely. Without accessible packaging, visually impaired individuals may face challenges in identifying their medications, which can lead to medication errors, missed doses, or adverse health outcomes.

Types of Braille Labels

  1. Embossed Labels
  2. Screen-Printed Braille
  3. Integral Braille
  4. Adhesive Labels
  5. Marburg Braille

       
            Figure 12.png
       

    (Figure 12)


       
            Figure 13.png
       

    (Figure 13)

Adherence Aids are essential components of patient-centric designs in pharmaceutical packaging, particularly for individuals managing chronic conditions. These aids, such as calendar packs and reminder systems, are specifically designed to enhance medication adherence by providing structured, easy-to-follow systems that help patients remember their medication schedules.  Medication adherence is a significant challenge in the management of chronic diseases. Research indicates that adherence rates often hover around 50% in developed countries, with forgetfulness being a major contributing factor to non-adherence . Non-adherence can lead to poor health outcomes, increased hospitalizations, and higher healthcare costs. Factors contributing to non-adherence include complex medication regimens, lack of understanding about the treatment's importance, and insufficient information provided during consultations. Adherence aids address these challenges by simplifying the medication-taking process and providing reminders that encourage patients to follow their prescribed regimens.

  1. Calendar Packs
  2. Visual Cues
  3. Compartmentalization
  4. Blister Packs
  5. Electronic Reminder Systems
  • Smart Pill Bottles
  • Mobile Applications
  • Automated Messaging Systems [28-34]

User-Friendly Interfaces in pharmaceutical packaging are crucial for ensuring that all patients, particularly the elderly and those with dexterity issues, can access their medications safely and easily. As the global population ages, the demand for packaging solutions that cater to these needs has become increasingly important.

The aging population often faces physical challenges such as reduced strength, arthritis, and diminished fine motor skills, making traditional packaging difficult to open. A study indicated that many older adults struggle with common packaging types, such as water bottles and food containers, which can lead to frustration and non-adherence to medication regimens. User-friendly packaging addresses these challenges by simplifying the opening process, thereby promoting independence and enhancing patient confidence in managing their medications.

  1. Easy-Open Caps and Lids
  2. Pull-Tab and Tear-Away Features
  3. Transparent Packaging
  4. Pictorial Instructions [35-38]

Regulatory Considerations

Compliance with Standards Strict regulatory considerations are applied to pharmaceutical packaging to guarantee safety, effectiveness, and adherence to several standards. Guidelines governing the packaging and labeling of pharmaceutical items are provided by regulatory agencies including the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA).

U.S. Food and Drug Administration (FDA) plays a critical role in regulating pharmaceutical packaging in the United States. The primary regulations governing packaging are outlined in the Code of Federal Regulations (CFR), particularly 21 CFR Part 211, which addresses current good manufacturing practices (cGMP) for pharmaceuticals. Key aspects include:

  1. Suitability for Intended Use
  2. Tamper-Evident Packaging
  3. Child-Resistant Packaging
  4. Labeling Requirement
  5. Quality Control Procedures

European Medicines Agency (EMA) provides regulatory guidance for pharmaceutical packaging within the European Union, emphasizing similar principles as those established by the FDA .

  1. Packaging Materials
  2. Tamper-Evident Features
  3. Child-Resistant Packaging
  4. Labeling Standards
  5. Good Manufacturing Practices [39-43]

Stability Testing Protocols are a critical aspect of pharmaceutical development, ensuring that medications maintain their quality, safety, and efficacy throughout their shelf life. The selection of appropriate packaging materials based on stability data is essential for preserving the integrity of pharmaceutical products.

Stability testing is designed to evaluate how a pharmaceutical product behaves under various environmental conditions over time. The primary objectives include:

  1. Determining Shelf Life
  2. Defining Storage Conditions
  3. Regulatory Compliance
  4. Quality Assurance
  5. Regulatory Framework [44-49]

Future Trends

The integration of Artificial Intelligence (AI) and the Internet of Things (IoT) into packaging is poised to revolutionize the pharmaceutical industry, creating smart packaging solutions that enhance communication between products and healthcare providers. This transformation not only improves operational efficiency but also significantly impacts patient care and medication management. Below is an exploration of the potential of AI and IoT in smart packaging, their applications, and the benefits they bring to healthcare.

  1. Enhanced Data Collection and Monitoring
  2. Communication with Healthcare Providers
  3. Personalized Patient Engagement
  4. Applications of Smart Packaging in Pharmaceuticals
  • Predictive Maintenance
  • Quality Control
  • Supply Chain Optimization

Benefits of Smart Packaging Solutions

  • Improved Patient Safety
  • Increased Adherence Rates
  • Enhanced Communication
  • Operational Efficiency
  • Sustainability [50-53]

Personalized Packaging Solutions are the future of pharmaceutical packaging is increasingly leaning towards personalized packaging solutions that cater to individual patient demographics and medication types. This trend is driven by advancements in technology, a greater understanding of patient needs, and the growing emphasis on personalized medicine. Below, we will explore the significance of personalized packaging solutions, their potential applications, and the implications for patient care.

Personalized packaging refers to the customization of pharmaceutical packaging based on specific patient demographics, medication types, and individual health needs. This approach aims to enhance the overall patient experience by making medications easier to manage and more effective in promoting adherence.

  1. Demographic-Specific Features
  2. Medication-Specific Customization
  3. Genetic-Based Customization

Implications for Patient Care

  • Enhanced Patient Engagement
  • Reduction in Medication Errors
  • Improved Health Outcomes
  • Cost-Effectiveness [9,54-58]

CONCLUSION

Innovative packaging plays a critical role in enhancing patient safety and compliance within the pharmaceutical industry. As the healthcare landscape evolves, packaging solutions are increasingly designed not only to protect medications but also to facilitate better patient engagement and adherence to treatment regimens.

Enhancing Patient Safety

  1. Tamper-Evident Features
  2. Child-Resistant Packaging
  3. Smart Packaging Technologies
  4. Active Packaging Solutions
  5. User-Friendly Designs
  6. Visual and Tactile Reminders
  7. Electronic Reminders
  8. Personalized Packaging Solutions

The need for ongoing research and development in pharmaceutical packaging technologies is becoming increasingly critical as the industry faces evolving challenges and opportunities. As highlighted by recent trends, advancements in technology, regulatory requirements, and patient expectations are driving the demand for innovative packaging solutions that enhance safety, compliance, and sustainability. Here are several key reasons emphasizing the importance of continuous R&D in this field:

  1. Advancements in Technology
  2. Regulatory Compliance
  3. Sustainability Initiatives
  4. Personalized Medicine
  5. Combatting Counterfeiting
  6. Enhancing Patient Engagement

REFERENCES

  1. Poitou P. Les missions du conditionnement en terme de sécurité et de bon usage du médicament [The role of the packaging in terms of safety and good use of medicines]. Ann Pharm Fr. 2003;61(5):300-3. French. PMID: 13130287.
  2. Nikam, S., Homepage, J., Nikam, S. M., Davange, M. D., & Patil, D. M. (2023). 416-432 | Review International Journal In Pharmaceutical Sciences 416|Page International Journal In Pharmaceutical Sciences A Review On Advancements In The Packaging Of Medicines. Int. J. in Pharm. Sci, 1. https://doi.org/10.5281/zenodo.10389787
  3. Kunal, M., Akhilesh, D., & Shyam Kumar, B. (n.d.). Recent Trends in Pharmaceutical Packaging: A Review. In INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES ISSN: 2277?5005 (Vol. 1, Issue 3). www.ijpcsonline.com1282
  4. Zadbuke N, Shahi S, Gulecha B, Padalkar A, Thube M. Recent trends and future of pharmaceutical packaging technology. J Pharm Bioallied Sci. 2013 Apr;5(2):98-110. doi: 10.4103/0975-7406.111820. PMID: 23833515; PMCID: PMC3697200.
  5. Jadhav, H. S., Kale, R. B., & Aher, 3akshay H. (2022). A REVIEW ON INNOVATIVE PACKAGING OF MEDICINE (Vol. 10). www.ijcrt.org
  6. Jadhav, S. P., Deore, S. D., Gajmal, G. K., Jadhav, S. P., Patil, D. M., & Sonawane, D. D. (2023). Study of different methods of Pharmaceutical Packaging. Article in Journal of Interdisiplinary Cycle Research. https://www.researchgate.net/publication/368445296
  7. A Review On Advancements In The Packaging Of Medicines. (n.d.). https://doi.org/10.5281/zenodo.10389787
  8. Chordiya, S. v, & Garge, B. M. (n.d.). Innovative packaging of medicines. In Review Article IP International Journal of Aesthetic and Health Rejuvenation (Vol. 2, Issue 4).
  9. Annex 9 Guidelines on packaging for pharmaceutical products. World Health Organization WHO Technical Report Series, No. 902, 2002
  10. Manoj Shivaji Kumbhar, Naresh Hiraram Choudhary, Deepak Annasaheb Dighe, Meera Chandradatt Singh , TAMPER EVIDENT PHARMACEUTICAL PACKAGING – NEEDS AND ADVANCES , International Journal of Pharmaceutical Sciences Review and Research , page 141-153
  11. Kunal, M., Akhilesh, D., & Shyam Kumar, B. (n.d.). Recent Trends in Pharmaceutical Packaging: A Review. In INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES ISSN: 2277?5005 (Vol. 1, Issue 3). www.ijpcsonline.com1282
  12. Pandey, P., Pal, R., Chanana, A., & Pal Singh, R. (n.d.). THE VARIOUS TYPES OF PACKAGING AND THEIR MATERIALS IN THE PHARMACEUTICAL PRODUCTS OR FORMULATIONS. https://www.researchgate.net/publication/369669032
  13. V, alFIya P., SaMuEl, M. P., mUrAlI, S., & DElFIya, anIESranI. (2017). KERALA KARSHAKAN e-journal.
  14. Dailin, D. J., & Rithwan, F. (2022). A Review on current status of plastic waste Biodegradation using microbial approach. https://www.researchgate.net/publication/363263600
  15. Nasa, P., Praveen Nasa, A., Singh Mahila Vishwavidyalaya, P., & Kalan, B. (2014). A REVIEW ON PHARMACEUTICAL PACKAGING MATERIAL. In 344 Praveen World Journal of Pharmaceutical Research (Vol. 3, Issue 5). www.wjpr.net
  16. aruna, S. M., & Rao, R. N. (n.d.). A Review on Packaging for Different Formulations.
  17. Ashiwaju, B. I., Orikpete, O. F., Fawole, A. A., Alade, E. Y., & Odogwu, C. (2023). A Step toward Sustainability: A Review of Biodegradable Packaging in the Pharmaceutical Industry. Matrix Science Pharma, 7(3), 73–84. https://doi.org/10.4103/mtsp.mtsp_22_23
  18. Popovi?, K., Živanovi?, S., & Jevti?, I. (2024). Biopolymer Packaging Materials in the Pharmaceutical Industry. AIDASCO Reviews, 2(1), 46–56. https://doi.org/10.59783/aire.2024.43
  19. https://www.swiftpak.co.uk/insights/anti-counterfeiting-in-pharmaceutical-packaging
  20. Falconnier-Williams, O. C., Taeschner, W., Hille, A., Falconnier, A. D., & Haefeli, W. E. (2024). Untapped options to reduce waste from blister packaging for tablets and capsules. European Journal of Clinical Pharmacology, 80(1), 151–161. https://doi.org/10.1007/s00228-023-03594-1
  21. https://www.weavabel.com/blog/from-popular-to-lesser-known-types-of-biodegradable-packaging
  22. https://meyers.com/meyers-blog/what-is-biodegradable-packaging/
  23. Mahe, E., Levaggi, R., Veronin, M., Ms, B., & #1, P. (n.d.). Packaging and Labeling of Pharmaceutical Products Obtained from the Internet.
  24. RAKESH NALAM. (2023). Essentials of pharmaceutical packaging to prevent drug counterfeiting. International Journal of Science and Research Archive, 9(2), 599–605. https://doi.org/10.30574/ijsra.2023.9.2.0610
  25. Annex 9 Guidelines on packaging for pharmaceutical products. (n.d.).
  26. Ran, X., Qu, Y., Wang, Y., Cui, B., Shen, Y., & Li, Y. (2023). Enhanced UV-Blocking Capabilities of Polylactic Acid Derived from Renewable Resources for Food and Drug Packaging: A Mini-Review. In Journal of Composites Science (Vol. 7, Issue 10). Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/jcs7100410
  27. https://www.europeanpharmaceuticalreview.com/article/117701/latest-innovations-in-child-resistant-pharmaceutical-packaging/
  28. Fernandez-Lazaro, C. I., García-González, J. M., Adams, D. P., Fernandez-Lazaro, D., Mielgo-Ayuso, J., Caballero-Garcia, A., Moreno Racionero, F., Córdova, A., & Miron-Canelo, J. A. (2019). Adherence to treatment and related factors among patients with chronic conditions in primary care: A cross-sectional study. BMC Family Practice, 20(1). https://doi.org/10.1186/s12875-019-1019-3
  29. Neiman, A. B., Ruppar, T., Ho, M., Garber, L., Weidle, P. J., Hong, Y., & Mary, ; (n.d.). Morbidity and Mortality Weekly Report (MMWR).
  30. Association between non-adherence behaviors, patients’ experience with healthcare and beliefs in medications_ a survey of patients with different chronic conditions. (n.d.).
  31. Rivera-Picón, C., Benavente-Cuesta, M. H., Quevedo-Aguado, M. P., Sánchez-González, J. L., & Rodríguez-Muñoz, P. M. (2023). Factors Associated with Adherence to Treatment in Patients with HIV and Diabetes Mellitus. Journal of Personalized Medicine, 13(2). https://doi.org/10.3390/jpm13020269
  32. Burnier, M. (2024). The role of adherence in patients with chronic diseases. In European Journal of Internal Medicine (Vol. 119, pp. 1–Elsevier B.V. https://doi.org/10.1016/j.ejim.2023.07.008
  33. Menditto, E., Orlando, V., de Rosa, G., Minghetti, P., Musazzi, U. M., Cahir, C., Kurczewska-Michalak, M., Kardas, P., Costa, E., Lobo, J. M. S., & Almeida, I. F. (2020). Patient centric pharmaceutical drug product design—the impact on medication adherence. In Pharmaceutics (Vol. 12, Issue 1). MDPI AG.https://doi.org/10.3390/pharmaceutics12010044
  34. Sekine, Y., Kawaguchi, T., Kunimoto, Y., Masuda, J., Numata, A., Hirano, A., Yagura, H., Ishihara, M., Hikasa, S., Tsukiji, M., Miyaji, T., Yamaguchi, T., Kinai, E., & Amano, K. (2023). Adherence to anti-retroviral therapy, decisional conflicts, and health-related quality of life among treatment-naïve individuals living with HIV: a DEARS-J observational study. Journal of Pharmaceutical Health Care and Sciences, 9(1). https://doi.org/10.1186/s40780-023-00277-y
  35. Bell AF, Walton KL, Tapsell LC. Easy to open? Exploring the 'openability' of hospital food and beverage packaging by older adults. Appetite. 2016 Mar 1;98:125-32. doi: 10.1016/j.appet.2015.12.004. Epub 2015 Dec 11. PMID: 26686584.
  36. https://www.healthcarepackaging.com/designmaterials/adherencedelivery/news/13282924/aging-population-demanding-easyopen-packages
  37. Sekine, Y., Kawaguchi, T., Kunimoto, Y., Masuda, J., Numata, A., Hirano, A., Yagura, H., Ishihara, M., Hikasa, S., Tsukiji, M., Miyaji, T., Yamaguchi, T., Kinai, E., & Amano, K. (2023). Adherence to anti-retroviral therapy, decisional conflicts, and health-related quality of life among treatment-naïve individuals living with HIV: a DEARS-J observational study. Journal of Pharmaceutical Health Care and Sciences, 9(1). https://doi.org/10.1186/s40780-023-00277-y
  38. https://eurpack.it/2024/04/29/developing-an-inclusive-senior-friendlypackaging/?lang=en
  39. Pharma Packaging Guidelines & Regulations in the USA | Origin
  40. Klemen?i?, M., Bolan?a Mirkovi?, I., & Bolf, N. (2023). The Influence of the Production Stages of Cardboard Pharmaceutical Packaging on the Circular Economy. Sustainability (Switzerland), 15(24). https://doi.org/10.3390/su152416882
  41. Takahashi, K., & Aldridge, A. A. (n.d.). Quality , Production, Laboratory, Materials , Facilities and Equipment Packaging and Labeling Regulatory Education for Industry (REdI): Focus on CGMPs & FDA Inspections Packaging & Labeling.
  42. Guidance for Industry Container Closure Systems for Packaging Human Drugs and Biologics CHEMISTRY, MANUFACTURING, AND CONTROLS DOCUMENTATION (Vol. 20857). (1999). Tel.
  43. Gahtori, A. U. (n.d.). Systematic Review Pharmacy 5 2 2 Recent Trends in Pharmaceutical Packaging. https://doi.org/10.31858/0975-8453.13.8.522-526
  44. Carli Lorenzini, G., & Olsson, A. (2022). Exploring How and Why to Develop Patient-Centered Packaging: A Multiple-Case Study with Pharmaceutical Companies. Therapeutic Innovation and Regulatory Science, 56(1), 117–129. https://doi.org/10.1007/s43441-021-00338-0
  45.  Salem, A., Abdelhedi, O., Sebii, H., Fakhfakh, N., Jr, M., Kechaou, H., Nasri, M., Debeaufort, F., & Zouari, N. (2022). Preparation and Characterization of Ecofriendly food Packaging Material by Smooth Hound Skin Gelatin Films/TiO2. https://doi.org/10.21203/rs.3.rs-1239574/v1
  46. https://aurigaresearch.com/pharmaceutical-testing/stability-testing/
  47. ICH Topic Q 1 E Evaluation of Stability Data Step 5 NOTE FOR GUIDANCE ON EVALUATION OF STABILITY DATA. (2003). http://www.emea.eu.int
  48. Pareek, V. (2014). Pharmaceutical packaging: Current trends and future. https://www.researchgate.net/publication/297091323
  49. https://humiditycontrol.com/blog/what-is-stability-testing/
  50. Bhat, J. (n.d.). Role of packaging material on Pharmaceutical product stability.
  51. Kasagani, V., & Kakollu, V. (2023). Design and Implementation of a Track n trace 2D Multi Scanner Bulk Code Reader for Pharmaceutical Packaging. International Journal of Life Science and Pharma Research. https://doi.org/10.22376/ijlpr.2023.13.2.p37-p50
  52. Campanella, B., Simoncini, M., Passaglia, E., Cicogna, F., Ciancaleoni, G., González-Rivera, J., Bernazzani, L., & Bramanti, E. (2024). Ecofriendly Preparation of Rosmarinic Acid-poly(vinyl alcohol) Biofilms Using NADES/DES, Ultrasounds and Optimization via a Mixture-Process Design Strategy. Materials, 17(2). https://doi.org/10.3390/ma17020377
  53. https://dragonflyai.co/resources/blog/how-ai-and-iot-are-transforming-packaging-design
  54. https://www.packaging-gateway.com/features/ai-smart-packaging-enhancing-customer-experience/
  55. Goetz, L. H., & Schork, N. J. (2018). Personalized medicine: motivation, challenges, and progress. In Fertility and Sterility (Vol. 109, Issue 6, pp. 952–963). Elsevier Inc. https://doi.org/10.1016/j.fertnstert.2018.05.006
  56. https://en.wikipedia.org/wiki/Personalized_medicine
  57. https://www.nature.com/scitable/topicpage/pharmacogenomics-and-personalized-medicine-643/
  58. Swarup Das, P., Saha, P., & Das, R. (n.d.). Pharmaceutical Packaging Technology: A Brief Outline

Reference

  1. Poitou P. Les missions du conditionnement en terme de sécurité et de bon usage du médicament [The role of the packaging in terms of safety and good use of medicines]. Ann Pharm Fr. 2003;61(5):300-3. French. PMID: 13130287.
  2. Nikam, S., Homepage, J., Nikam, S. M., Davange, M. D., & Patil, D. M. (2023). 416-432 | Review International Journal In Pharmaceutical Sciences 416|Page International Journal In Pharmaceutical Sciences A Review On Advancements In The Packaging Of Medicines. Int. J. in Pharm. Sci, 1. https://doi.org/10.5281/zenodo.10389787
  3. Kunal, M., Akhilesh, D., & Shyam Kumar, B. (n.d.). Recent Trends in Pharmaceutical Packaging: A Review. In INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES ISSN: 2277?5005 (Vol. 1, Issue 3). www.ijpcsonline.com1282
  4. Zadbuke N, Shahi S, Gulecha B, Padalkar A, Thube M. Recent trends and future of pharmaceutical packaging technology. J Pharm Bioallied Sci. 2013 Apr;5(2):98-110. doi: 10.4103/0975-7406.111820. PMID: 23833515; PMCID: PMC3697200.
  5. Jadhav, H. S., Kale, R. B., & Aher, 3akshay H. (2022). A REVIEW ON INNOVATIVE PACKAGING OF MEDICINE (Vol. 10). www.ijcrt.org
  6. Jadhav, S. P., Deore, S. D., Gajmal, G. K., Jadhav, S. P., Patil, D. M., & Sonawane, D. D. (2023). Study of different methods of Pharmaceutical Packaging. Article in Journal of Interdisiplinary Cycle Research. https://www.researchgate.net/publication/368445296
  7. A Review On Advancements In The Packaging Of Medicines. (n.d.). https://doi.org/10.5281/zenodo.10389787
  8. Chordiya, S. v, & Garge, B. M. (n.d.). Innovative packaging of medicines. In Review Article IP International Journal of Aesthetic and Health Rejuvenation (Vol. 2, Issue 4).
  9. Annex 9 Guidelines on packaging for pharmaceutical products. World Health Organization WHO Technical Report Series, No. 902, 2002
  10. Manoj Shivaji Kumbhar, Naresh Hiraram Choudhary, Deepak Annasaheb Dighe, Meera Chandradatt Singh , TAMPER EVIDENT PHARMACEUTICAL PACKAGING – NEEDS AND ADVANCES , International Journal of Pharmaceutical Sciences Review and Research , page 141-153
  11. Kunal, M., Akhilesh, D., & Shyam Kumar, B. (n.d.). Recent Trends in Pharmaceutical Packaging: A Review. In INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES ISSN: 2277?5005 (Vol. 1, Issue 3). www.ijpcsonline.com1282
  12. Pandey, P., Pal, R., Chanana, A., & Pal Singh, R. (n.d.). THE VARIOUS TYPES OF PACKAGING AND THEIR MATERIALS IN THE PHARMACEUTICAL PRODUCTS OR FORMULATIONS. https://www.researchgate.net/publication/369669032
  13. V, alFIya P., SaMuEl, M. P., mUrAlI, S., & DElFIya, anIESranI. (2017). KERALA KARSHAKAN e-journal.
  14. Dailin, D. J., & Rithwan, F. (2022). A Review on current status of plastic waste Biodegradation using microbial approach. https://www.researchgate.net/publication/363263600
  15. Nasa, P., Praveen Nasa, A., Singh Mahila Vishwavidyalaya, P., & Kalan, B. (2014). A REVIEW ON PHARMACEUTICAL PACKAGING MATERIAL. In 344 Praveen World Journal of Pharmaceutical Research (Vol. 3, Issue 5). www.wjpr.net
  16. aruna, S. M., & Rao, R. N. (n.d.). A Review on Packaging for Different Formulations.
  17. Ashiwaju, B. I., Orikpete, O. F., Fawole, A. A., Alade, E. Y., & Odogwu, C. (2023). A Step toward Sustainability: A Review of Biodegradable Packaging in the Pharmaceutical Industry. Matrix Science Pharma, 7(3), 73–84. https://doi.org/10.4103/mtsp.mtsp_22_23
  18. Popovi?, K., Živanovi?, S., & Jevti?, I. (2024). Biopolymer Packaging Materials in the Pharmaceutical Industry. AIDASCO Reviews, 2(1), 46–56. https://doi.org/10.59783/aire.2024.43
  19. https://www.swiftpak.co.uk/insights/anti-counterfeiting-in-pharmaceutical-packaging
  20. Falconnier-Williams, O. C., Taeschner, W., Hille, A., Falconnier, A. D., & Haefeli, W. E. (2024). Untapped options to reduce waste from blister packaging for tablets and capsules. European Journal of Clinical Pharmacology, 80(1), 151–161. https://doi.org/10.1007/s00228-023-03594-1
  21. https://www.weavabel.com/blog/from-popular-to-lesser-known-types-of-biodegradable-packaging
  22. https://meyers.com/meyers-blog/what-is-biodegradable-packaging/
  23. Mahe, E., Levaggi, R., Veronin, M., Ms, B., & #1, P. (n.d.). Packaging and Labeling of Pharmaceutical Products Obtained from the Internet.
  24. RAKESH NALAM. (2023). Essentials of pharmaceutical packaging to prevent drug counterfeiting. International Journal of Science and Research Archive, 9(2), 599–605. https://doi.org/10.30574/ijsra.2023.9.2.0610
  25. Annex 9 Guidelines on packaging for pharmaceutical products. (n.d.).
  26. Ran, X., Qu, Y., Wang, Y., Cui, B., Shen, Y., & Li, Y. (2023). Enhanced UV-Blocking Capabilities of Polylactic Acid Derived from Renewable Resources for Food and Drug Packaging: A Mini-Review. In Journal of Composites Science (Vol. 7, Issue 10). Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/jcs7100410
  27. https://www.europeanpharmaceuticalreview.com/article/117701/latest-innovations-in-child-resistant-pharmaceutical-packaging/
  28. Fernandez-Lazaro, C. I., García-González, J. M., Adams, D. P., Fernandez-Lazaro, D., Mielgo-Ayuso, J., Caballero-Garcia, A., Moreno Racionero, F., Córdova, A., & Miron-Canelo, J. A. (2019). Adherence to treatment and related factors among patients with chronic conditions in primary care: A cross-sectional study. BMC Family Practice, 20(1). https://doi.org/10.1186/s12875-019-1019-3
  29. Neiman, A. B., Ruppar, T., Ho, M., Garber, L., Weidle, P. J., Hong, Y., & Mary, ; (n.d.). Morbidity and Mortality Weekly Report (MMWR).
  30. Association between non-adherence behaviors, patients’ experience with healthcare and beliefs in medications_ a survey of patients with different chronic conditions. (n.d.).
  31. Rivera-Picón, C., Benavente-Cuesta, M. H., Quevedo-Aguado, M. P., Sánchez-González, J. L., & Rodríguez-Muñoz, P. M. (2023). Factors Associated with Adherence to Treatment in Patients with HIV and Diabetes Mellitus. Journal of Personalized Medicine, 13(2). https://doi.org/10.3390/jpm13020269
  32. Burnier, M. (2024). The role of adherence in patients with chronic diseases. In European Journal of Internal Medicine (Vol. 119, pp. 1–Elsevier B.V. https://doi.org/10.1016/j.ejim.2023.07.008
  33. Menditto, E., Orlando, V., de Rosa, G., Minghetti, P., Musazzi, U. M., Cahir, C., Kurczewska-Michalak, M., Kardas, P., Costa, E., Lobo, J. M. S., & Almeida, I. F. (2020). Patient centric pharmaceutical drug product design—the impact on medication adherence. In Pharmaceutics (Vol. 12, Issue 1). MDPI AG.https://doi.org/10.3390/pharmaceutics12010044
  34. Sekine, Y., Kawaguchi, T., Kunimoto, Y., Masuda, J., Numata, A., Hirano, A., Yagura, H., Ishihara, M., Hikasa, S., Tsukiji, M., Miyaji, T., Yamaguchi, T., Kinai, E., & Amano, K. (2023). Adherence to anti-retroviral therapy, decisional conflicts, and health-related quality of life among treatment-naïve individuals living with HIV: a DEARS-J observational study. Journal of Pharmaceutical Health Care and Sciences, 9(1). https://doi.org/10.1186/s40780-023-00277-y
  35. Bell AF, Walton KL, Tapsell LC. Easy to open? Exploring the 'openability' of hospital food and beverage packaging by older adults. Appetite. 2016 Mar 1;98:125-32. doi: 10.1016/j.appet.2015.12.004. Epub 2015 Dec 11. PMID: 26686584.
  36. https://www.healthcarepackaging.com/designmaterials/adherencedelivery/news/13282924/aging-population-demanding-easyopen-packages
  37. Sekine, Y., Kawaguchi, T., Kunimoto, Y., Masuda, J., Numata, A., Hirano, A., Yagura, H., Ishihara, M., Hikasa, S., Tsukiji, M., Miyaji, T., Yamaguchi, T., Kinai, E., & Amano, K. (2023). Adherence to anti-retroviral therapy, decisional conflicts, and health-related quality of life among treatment-naïve individuals living with HIV: a DEARS-J observational study. Journal of Pharmaceutical Health Care and Sciences, 9(1). https://doi.org/10.1186/s40780-023-00277-y
  38. https://eurpack.it/2024/04/29/developing-an-inclusive-senior-friendlypackaging/?lang=en
  39. Pharma Packaging Guidelines & Regulations in the USA | Origin
  40. Klemen?i?, M., Bolan?a Mirkovi?, I., & Bolf, N. (2023). The Influence of the Production Stages of Cardboard Pharmaceutical Packaging on the Circular Economy. Sustainability (Switzerland), 15(24). https://doi.org/10.3390/su152416882
  41. Takahashi, K., & Aldridge, A. A. (n.d.). Quality , Production, Laboratory, Materials , Facilities and Equipment Packaging and Labeling Regulatory Education for Industry (REdI): Focus on CGMPs & FDA Inspections Packaging & Labeling.
  42. Guidance for Industry Container Closure Systems for Packaging Human Drugs and Biologics CHEMISTRY, MANUFACTURING, AND CONTROLS DOCUMENTATION (Vol. 20857). (1999). Tel.
  43. Gahtori, A. U. (n.d.). Systematic Review Pharmacy 5 2 2 Recent Trends in Pharmaceutical Packaging. https://doi.org/10.31858/0975-8453.13.8.522-526
  44. Carli Lorenzini, G., & Olsson, A. (2022). Exploring How and Why to Develop Patient-Centered Packaging: A Multiple-Case Study with Pharmaceutical Companies. Therapeutic Innovation and Regulatory Science, 56(1), 117–129. https://doi.org/10.1007/s43441-021-00338-0
  45.  Salem, A., Abdelhedi, O., Sebii, H., Fakhfakh, N., Jr, M., Kechaou, H., Nasri, M., Debeaufort, F., & Zouari, N. (2022). Preparation and Characterization of Ecofriendly food Packaging Material by Smooth Hound Skin Gelatin Films/TiO2. https://doi.org/10.21203/rs.3.rs-1239574/v1
  46. https://aurigaresearch.com/pharmaceutical-testing/stability-testing/
  47. ICH Topic Q 1 E Evaluation of Stability Data Step 5 NOTE FOR GUIDANCE ON EVALUATION OF STABILITY DATA. (2003). http://www.emea.eu.int
  48. Pareek, V. (2014). Pharmaceutical packaging: Current trends and future. https://www.researchgate.net/publication/297091323
  49. https://humiditycontrol.com/blog/what-is-stability-testing/
  50. Bhat, J. (n.d.). Role of packaging material on Pharmaceutical product stability.
  51. Kasagani, V., & Kakollu, V. (2023). Design and Implementation of a Track n trace 2D Multi Scanner Bulk Code Reader for Pharmaceutical Packaging. International Journal of Life Science and Pharma Research. https://doi.org/10.22376/ijlpr.2023.13.2.p37-p50
  52. Campanella, B., Simoncini, M., Passaglia, E., Cicogna, F., Ciancaleoni, G., González-Rivera, J., Bernazzani, L., & Bramanti, E. (2024). Ecofriendly Preparation of Rosmarinic Acid-poly(vinyl alcohol) Biofilms Using NADES/DES, Ultrasounds and Optimization via a Mixture-Process Design Strategy. Materials, 17(2). https://doi.org/10.3390/ma17020377
  53. https://dragonflyai.co/resources/blog/how-ai-and-iot-are-transforming-packaging-design
  54. https://www.packaging-gateway.com/features/ai-smart-packaging-enhancing-customer-experience/
  55. Goetz, L. H., & Schork, N. J. (2018). Personalized medicine: motivation, challenges, and progress. In Fertility and Sterility (Vol. 109, Issue 6, pp. 952–963). Elsevier Inc. https://doi.org/10.1016/j.fertnstert.2018.05.006
  56. https://en.wikipedia.org/wiki/Personalized_medicine
  57. https://www.nature.com/scitable/topicpage/pharmacogenomics-and-personalized-medicine-643/
  58. Swarup Das, P., Saha, P., & Das, R. (n.d.). Pharmaceutical Packaging Technology: A Brief Outline

Photo
Saurabh Argade
Corresponding author

Department of Pharmaceutics, Pravara Rural College of Pharmacy, Pravaranagar 413736

Photo
Someshwar Mankar
Co-author

Department of Pharmaceutics, Pravara Rural College of Pharmacy, Pravaranagar 413736

Photo
Suhas Siddheshwar
Co-author

Department of Pharmaceutics, Pravara Rural College of Pharmacy, Pravaranagar 413736

Saurabh Argade*, Someshwar Mankar, Suhas Siddheshwar, Revolutionizing Pharmaceutical Packaging: A Comprehensive Review of Current Trends and Future Directions, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 01, 265-277. https://doi.org/10.5281/zenodo.14602999

More related articles
Insights into immune thrombocytopenic purpura: a r...
Dhanya Dharman , Ahalya U, Praveena R Prasad, Shaiju S Dharan, ...
Eco-Friendly Pest Control: Evaluating The Insectic...
Grace Cornelius , Dr Rashmi Sharma , ...
Formulation And Evaluation Of Herbal Cream For Man...
Kartiki Dnyaneshwar More , Pankaj Vishnu Vyawhare , ...
Mpox - Rapidly implementing Disease ...
Borphale Pallavi Rajendra , Patel Muskan Rajjak, Dharashive Pradnya Shivsamb, Giram Tushar Bankat , ...
Phytochemical Analysis and Quantification of Bioactive Compounds in Ethanolic Ex...
Arnab Roy, Ankita Singh, Nahida Khatun, Divya Roshni Panna, Priyanka Kumari, Suman Kumari, Bina Kuma...
Related Articles
Formulation And Development Of Bilayer Tablets Of Cimetidine And Sucralfate For ...
Naumaan Naeem shaikh, Pradnya Palekar, Shanbhag Sanjana Jadhav, Samiksha Shinde, Akshaya Aravamudhan...
A Review On Nano-Advantage: Why Nano-Niosomes Are Gaining Preference Over Tradit...
Sharayu S.Kumbhar, Radhika S. Subhedar, Nilesh B. Chougule, ...
A Detailed Pythopharmacological And Biochemical Review On Mimosa Pudica (Laajvan...
Syed Mohammad Abdullah, Anuska Shivani, Raushan Kumar, Aditya Kumar, Raunak Kumar Singh, ...
Insights into immune thrombocytopenic purpura: a rare hematological disorder ...
Dhanya Dharman , Ahalya U, Praveena R Prasad, Shaiju S Dharan, ...